For years the conversation around iron and women was always about deficiency — eat more spinach, take a supplement, check your ferritin. The idea that iron could become a problem after menopause felt completely counterintuitive the first time I came across the research. But once you understand what iron actually does when it isn't being lost every month, it changes how you think about everything from fatigue to heart health in your fifties and beyond.
Learn more about Rose →Menstruation removed roughly 15–30 mg of iron per month, which kept systemic iron levels in a naturally controlled range for decades. The human body has no dedicated excretion pathway for iron — unlike most minerals, it cannot simply be excreted in urine or stool in meaningful quantities. Once periods stop, that monthly release valve closes permanently, and iron begins to accumulate unless dietary intake or other losses compensate.
Estrogen downregulates hepcidin — the liver hormone that controls how much iron the gut absorbs from food — but it also has direct effects on ferroportin, the transporter that moves iron out of intestinal cells and into circulation. As estrogen declines during perimenopause, this regulatory influence weakens, and the gut becomes less precise about limiting iron uptake. The result is that even a diet that was once iron-balanced can tip toward net accumulation.
Hepcidin is the master regulator of iron homeostasis, produced by the liver in response to iron stores and inflammation. Post-menopausal women show higher baseline hepcidin levels compared to premenopausal women, which paradoxically reflects the body trying to protect against rising iron stores rather than a sign that absorption is being appropriately blocked. Elevated hepcidin also suppresses iron recycling from red blood cells, which can alter the entire distribution of iron across tissues.
Population studies consistently show that serum ferritin — the protein that stores iron inside cells — rises significantly in the years following the final menstrual period. By the time a woman is five to ten years post-menopause, her ferritin levels often resemble those seen in men of the same age, a pattern that was virtually impossible while she was menstruating. High ferritin is not inherently dangerous, but it is a marker that iron is accumulating in tissues including the liver, heart, and joints.
Free iron participates directly in the Fenton reaction — a chemical process that converts relatively harmless hydrogen peroxide into hydroxyl radicals, among the most damaging free radicals known to biology. These radicals attack cell membranes, mitochondrial DNA, and LDL cholesterol particles, accelerating the cellular damage that underlies aging and chronic disease. This is one reason why the post-menopausal rise in iron stores is considered a plausible contributor to the increase in oxidative stress markers observed in midlife women.
Before menopause, women have substantially lower rates of cardiovascular disease than men of the same age — a protection that begins eroding during the menopause transition. The iron hypothesis, first proposed by Jerome Sullivan in 1981 and since supported by observational data, suggests that lower lifetime iron stores in premenopausal women contribute to this protection. After menopause, as iron stores converge toward male levels, so does cardiovascular risk — though estrogen loss and other metabolic shifts are clearly also involved.
Synovial tissue — the lining of joints — can accumulate iron, and elevated iron in joint fluid is associated with cartilage degradation and inflammation. Women who experience the well-documented increase in joint pain during and after menopause are rarely told that shifting iron dynamics may be a contributing factor alongside estrogen withdrawal. Research in conditions like haemochromatosis, where iron overload is severe, shows dramatic joint damage, and milder accumulation in the post-menopausal range may contribute to lower-grade joint symptoms.
Many women enter perimenopause still supplementing iron for long-standing deficiency related to heavy periods — but as bleeding reduces and eventually stops, continuing those supplements without retesting ferritin can lead to unintended accumulation. A ferritin level that was once low-normal can move into high-normal or elevated territory within months of periods becoming irregular or stopping. Supplementing iron without current bloodwork during and after the menopause transition is something worth discussing specifically with a GP or haematologist.
Because the body cannot excrete excess iron efficiently, the most evidence-supported strategies for managing post-menopausal iron accumulation are reducing haem iron intake (red meat in particular), increasing consumption of polyphenol-rich foods that gently inhibit iron absorption, and — for those with elevated ferritin — considering blood donation, which remains one of the most effective ways to remove iron from the body. Regular ferritin testing every few years after menopause gives women the data they need to make informed choices, yet it is rarely offered as routine care.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.